Results 231 to 240 of about 50,155,014 (329)

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

A conversation with Mehdi Shishehbor, DO, MPH, PhD, President, Harrington Heart & Vascular Institute and Professor of Medicine, Cleveland University Hospitals Cleveland Medical Center

Journal of Clinical and Translational Science
Clinical Research Forum
doaj   +1 more source

Research on the livelihood capital and livelihood strategies of resettlement in China’s South-to-North Water Diversion Middle Line Project [PDF]

Qian Li, Yi Xu, Xue Zhao, Jiaxiao Xie, Tianyi Jiao, Zhaoxian Su   +5 more
openalex   +1 more source

Paths of legal recognition of genetic counselors in Canada: A framework for action. [PDF]

J Genet Couns
Patrinos D, Bonilha AE, Knoppers BM, Elliott AM, GenCOUNSEL Study, Zawati MH.   +5 more
europepmc   +1 more source

Third Kurultai held in simferopol [PDF]

, 1999
Research, Update
core  

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Research/Researchers [PDF]

MRS Bulletin, 1986
openaire   +1 more source

The 'shades of grey' in research integrity-Researchers admit to questionable research practices that they do not perceive to be serious. [PDF]

PLoS One
Entradas M, Feng Y, Sousa ICE.
europepmc   +1 more source

President gets a new political council [PDF]

, 2001
Research, Update
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source